Neuropace Inc (NPCE) is set to release its SEP/2025 earnings performance on 11/04 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 24.64M and an earnings per share (EPS) of -0.20 for the SEP/2025. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call presents a mixed outlook. While revenue and gross margin have improved, the company still reports a net loss. Regulatory risks and uncertainties regarding 2026 financial goals may cause investor caution. The absence of a shareholder return plan or new partnerships limits positive catalysts. The market might react neutrally, awaiting further clarity on regulatory outcomes and financial performance.
NeuroPace's earnings call reveals strong financial performance with significant revenue and gross margin growth, positive adjusted EBITDA, and reduced net loss. The raised revenue and gross margin guidance for 2025 further indicates optimism. Despite increased operating expenses, the strategic focus on RNS and upcoming FDA submissions, combined with favorable analyst sentiment, supports a positive outlook. The Q&A section highlights the potential of generalized epilepsy opportunities and Project CARE's growth contribution, reinforcing positive sentiment. Given these factors, a positive stock price reaction is expected over the next two weeks.
The earnings call summary shows positive revenue and gross margin guidance, strong clinical trial results, and AI tool launches. Despite some uncertainties in the Q&A, such as lack of specific milestones in partnerships and unclear responses, the raised guidance and strategic initiatives suggest a positive outlook. The positive sentiment is further supported by optimistic growth expectations and strategic focus on RNS expansion. Given these factors, the stock price is likely to experience a positive movement in the short term.
Neuropace Inc (NPCE) is scheduled to release its FY2025Q3 earnings report on Nov 4, 2025, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 24.64M in revenue and an EPS of -0.20 for Neuropace Inc's FY2025Q3.
Intellectia's exclusive AI algorithms forecast a {conclusion} for Neuropace Inc's FY2025Q3 earnings, with a prediction date of Nov 4, 2025. Neuropace Inc {summary}
Leverage Intellectia's AI forecast to position trades ahead of the Nov 4, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!